These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 35193066)
1. Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors. Wang Z; Liu R; Zhang X; Chang X; Gao M; Zhang S; Guan Q; Sun J; Zuo D; Zhang W Bioorg Med Chem; 2022 Mar; 58():116671. PubMed ID: 35193066 [TBL] [Abstract][Full Text] [Related]
2. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and bioevaluation of 2,7-diaryl-pyrazolo[1,5-a]pyrimidines as tubulin polymerization inhibitors. Liu R; Zhang S; Huang M; Guo Z; Li L; Li M; Wu L; Guan Q; Zhang W Bioorg Chem; 2021 Oct; 115():105220. PubMed ID: 34352709 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors. Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities. Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities. Ren Y; Ruan Y; Cheng B; Li L; Liu J; Fang Y; Chen J Bioorg Med Chem; 2021 Sep; 46():116376. PubMed ID: 34455231 [TBL] [Abstract][Full Text] [Related]
7. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo. Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of novel 2,3-Di-O-Aryl/Alkyl sulfonate derivatives of l-ascorbic acid: Efficient access to novel anticancer agents via in vitro screening, tubulin polymerization inhibition, molecular docking study and ADME predictions. Deshmukh SR; Nalkar AS; Sarkate AP; Tiwari SV; Lokwani DK; Thopate SR Bioorg Chem; 2024 Jun; 147():107402. PubMed ID: 38688199 [TBL] [Abstract][Full Text] [Related]
9. Identification of gallic acid based glycoconjugates as a novel tubulin polymerization inhibitors. Upadhyaya K; Hamidullah ; Singh K; Arun A; Shukla M; Srivastava N; Ashraf R; Sharma A; Mahar R; Shukla SK; Sarkar J; Ramachandran R; Lal J; Konwar R; Tripathi RP Org Biomol Chem; 2016 Jan; 14(4):1338-58. PubMed ID: 26659548 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines. Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors. Liang T; Zhou X; Lu L; Dong H; Zhang Y; Xu Y; Qi J; Zhang Y; Wang J Bioorg Chem; 2021 May; 110():104793. PubMed ID: 33770673 [TBL] [Abstract][Full Text] [Related]
12. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors. Rahimzadeh Oskuei S; Mirzaei S; Reza Jafari-Nik M; Hadizadeh F; Eisvand F; Mosaffa F; Ghodsi R Bioorg Chem; 2021 Jul; 112():104904. PubMed ID: 33933802 [TBL] [Abstract][Full Text] [Related]
14. Identification of Essential 2D and 3D Chemical Features for Discovery of the Novel Tubulin Polymerization Inhibitors. Azimi F; Ghasemi JB; Saghaei L; Hassanzadeh F; Mahdavi M; Sadeghi-Aliabadi H; Scotti MT; Scotti L Curr Top Med Chem; 2019; 19(13):1092-1120. PubMed ID: 31109275 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities. Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site. Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319 [TBL] [Abstract][Full Text] [Related]
17. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation. Hagras M; El Deeb MA; Elzahabi HSA; Elkaeed EB; Mehany ABM; Eissa IH J Enzyme Inhib Med Chem; 2021 Dec; 36(1):640-658. PubMed ID: 33588683 [TBL] [Abstract][Full Text] [Related]